The results of PLUS underscore the utility of mirabegron add-on therapy to treat men with overactive bladder symptoms receiving tamsulosin for benign prostatic hyperplasia.
No takes yet. Share an insight, caveat, or question.
Kaplan et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context:
More from The Journal of Urology